GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Enterprise Value

ClouDr Group (HKSE:09955) Enterprise Value : HK$1,219 Mil (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ClouDr Group's Enterprise Value is HK$1,219 Mil. ClouDr Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-346 Mil. Therefore, ClouDr Group's EV-to-EBIT ratio for today is -3.52.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, ClouDr Group's Enterprise Value is HK$1,219 Mil. ClouDr Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-346 Mil. Therefore, ClouDr Group's EV-to-EBITDA ratio for today is -3.52.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, ClouDr Group's Enterprise Value is HK$1,219 Mil. ClouDr Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,037 Mil. Therefore, ClouDr Group's EV-to-Revenue ratio for today is 0.30.


ClouDr Group Enterprise Value Historical Data

The historical data trend for ClouDr Group's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Enterprise Value Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
- - - 7,355.69 3,596.75

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial - - 7,355.69 4,188.73 3,596.75

Competitive Comparison of ClouDr Group's Enterprise Value

For the Medical Distribution subindustry, ClouDr Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClouDr Group's Enterprise Value Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Enterprise Value distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Enterprise Value falls into.



ClouDr Group Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

ClouDr Group's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

ClouDr Group's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ClouDr Group  (HKSE:09955) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

ClouDr Group's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1218.709/-346.229
=-3.52

ClouDr Group's current Enterprise Value is HK$1,219 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-346 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

ClouDr Group's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1218.709/-346.229
=-3.52

ClouDr Group's current Enterprise Value is HK$1,219 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-346 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

ClouDr Group's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1218.709/4036.633
=0.30

ClouDr Group's current Enterprise Value is HK$1,219 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. ClouDr Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$4,037 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ClouDr Group Enterprise Value Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ClouDr Group (HKSE:09955) Business Description

Traded in Other Exchanges
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
Executives
Trident Trust Company (hk) Limited 2301 Trustee
Data Vantage Development Limited 2201 Interest of corporation controlled by you
Kuang Ming 2201 Interest of corporation controlled by you
Prime Forest Assets Limited 2101 Beneficial owner
Shang Hai Qi Ji Ke Ji He Huo Qi Ye You Xian He Huo
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Zhao Yin Guo Ji Jin Rong You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Ho Chi Sing 2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.
Zhou Quan 2201 Interest of corporation controlled by you
Idg China Venture Capital Fund Gp Iv Associates Ltd. 2201 Interest of corporation controlled by you
Haoyuan Health Limited 2101 Beneficial owner
Yass Jeffrey Steven

ClouDr Group (HKSE:09955) Headlines

No Headlines